الفهرس 
Effect of intracoronary (IC) tirofiban following aspiration thrombectomy on infarct size, in patients with large anterior STEMI undergoing primary PCI
ContentsOnly 14 pages are availabe for public view
 |  | from | 174 |  |  |
| | | from | 174 | | |
Abstract
Evaluable MRI results at 30 days where present in only 40 of 50 patients (80%), with the most common reasons for missing data being patient re-infarction prior to 30 days and inability to tolerate the procedure. Patients randomized to IC Tirofiban compared with no IC Tirofiban had a significant reduction at 30 days infarct size (median, 15451 mm3 - IQR, 17404 mm3 - n=20) vs (median, 43828 mm3 - IQR, 49599 mm3 - n=20) P value= 0.002. Patients randomized to IC Tirofiban compared with no IC Tirofiban had no significant in MBG post PCI (P value= 0.67). In patients with large anterior STEMI presenting early after symptom onset and undergoing primary PCI, infarct size at 30 days was significantly reduced by bolus IC Tirofiban delivered to the infarct lesion site following manual Aspiration Thrombectomy. There is no significance in MACE at 30 days between patients received bolus IC Tirofiban and patients who did not receive (P value= 0.723).